Author(s): Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S, Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S, Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S, Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S
Abstract Share this page
Abstract BACKGROUND: The Hospital Anxiety and Depression Scale (HADS) is a widely used instrument to measure psychological morbidity in cancer patients. This study aimed to translate and test the reliability and validity of the Iranian version of the HADS. METHODS: The English language version of the HADS was translated into Persian (Iranian language) and was used in this study. The questionnaire was administered to a consecutive sample of 167 breast cancer patients and statistical analysis was performed to test the reliability and validity of the HADS. RESULTS: In general the Iranian version of the HADS was found to be acceptable to almost all patients (99\%). Cronbach's alpha coefficient (to test reliability) has been found to be 0.78 for the HADS anxiety sub-scale and 0.86 for the HADS depression sub-scale. Validity as performed using known groups comparison analysis showed satisfactory results. Both anxiety and depression sub-scales discriminated well between sub-groups of patients differing in clinical status as defined by their disease stage. CONCLUSION: This preliminary validation study of the Iranian version of the HADS proved that it is an acceptable, a reliable and valid measure of psychological distress among cancer patients.
This article was published in Health Qual Life Outcomes
and referenced in Journal of Clinical Trials